Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics

Nucleic Acids Research

Volumn 36, Issue 3, 2008, Pages 756-769

  Sánchez, Ignacio G ^a   Dellarole, Mariano ^a   Gaston, Kevin ^b   de Prat Gay, Gonzalo ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS PROTEIN E2;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; ENERGY; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN METHYLATION; REGULATORY MECHANISM; VIRUS GENOME; VIRUS REPLICATION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; BINDING SITES; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; CPG ISLANDS; DATA INTERPRETATION, STATISTICAL; DNA METHYLATION; DNA, VIRAL; DNA-BINDING PROTEINS; EVOLUTION, MOLECULAR; GENOMICS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROTEIN BINDING; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE;

EID: 39449099343     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm1104     Document Type: Article

References (97)

1. Bosch,F.X., Sanjosé,S., Castellsagué, X., Moreno,V. and Muñoz,N. (2006) In Saveria Campo,M. (ed.), Papillomavirus Research: From Natural History to, Vaccines and Beyond. Caisreir Academic Press, Wymondharn, Vol. Chapter 3, pp. 19-40.
2. Munoz,N., Bosch,F.X, de Sanjose, S., Herrero,R., Castellsague,X., Shah,K.V., Snijders,P.J. and Meijer,C.J. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med., 348, 518-527.
3. de Villiers,E.M., Fauquet,C., Broker,T.R., Bernard,H.U. and zur Hausen,H. (2004) Classification of papillomaviruses. Virology, 324, 17-27.
4. Bravo,I G. and Alonso,A. (2007) Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins. Virus Genes, 34, 249-262.
5. D'Souza,G., Kreimer,A.R., Viscidi,R., Pawlita,M., Fakhry,C., Koch,W. M., Westra,W.H. and Gillison,M.L. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med., 356 1944-1956.
6. Cohen J. (2005) Public health. High hopes and dilemmas for a cervical cancer vaccine. Science, 308, 618-621.
7. Kalantari,M. and Bernard, H-U. (2006) In Saveria Campo,M. (ed.), Papillomavirus Research: From Natural History to Vaccines and Beyond. Caisreir Academic Press, Wymondham, Vol. Chapter 4, pp. 41-52.
8. Hegde,R.S. (2002) The papillomavirus E2 proteins: Structure, function, and biology. Annu. Rev. Biophys. Biomol. Struct., 31, 343-360.
9. McBride,A.A., Byrne,J.C. and Howley,P.M. (1989) E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: Transactivation is mediated by the conserved amino-terminal domain. Proc. Natl Acad. Sci. USA, 86, 510-514.
10. Mok,Y.K., de Prat Gay,G., Butler,P.J. and Bycroft,M. (1996) Equilibrium dissociation and unfolding of the dimeric human, papillomavirus strain-16 E2 DNA-binding domain. Protein Sci., 5, 310-319.
11. McBride.A.A., Romanczuk.H. and Howley,P.M. (1991) The papil-lomavirus E2 regulatory proteins. J. Biol. Chem., 266, 18411-18414.
12. Blakaj,D.M., Kattamuri,C., Khrapunov,S., Hegde,R.S. and Brenowitz,M. (2006) Indirect readout of DNA sequence by papillomavirus E2 proteins depends upon net cation uptake. J. Mol. Biol., 358, 224-240.
13. Thain,A., Webster,K., Emery,D., Clarke,A.R. and Gaston,K. (1997) DNA binding and bending by the human papillomavirus type 16 E2 protein. Recognition of an extended binding site. J. Biol. Chem., 272 8236-8242.
14. Thain,A., Jenkins,O., Clarke,A.R. and Gaston,K. (1996) CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol., 70, 7233-7235.
15. Sanders,C.M. and Maitland,N.J. (1994) Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements. Nucleic Acids Res., 22, 4890-4897.
16. Zhang,Y., Xi,Z., Hegde,R.S., Shakked,Z. and Crothers, D.M. (2004) Predicting indirect readout effects in protein-DNA interactions. Proc. Natl Acad. Sci. USA. 101, 8337-8341.
17. Dell,G., Wilkinson,K.W., Tranter,R., Parish,J., Leo Brady,R. and Gaston,K. (2001) Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus. J. Mol, Biol., 334, 979-991.
18. Hines,CS., Meghoo;C., Shetty,S., Biburger,M., Brenowitz,M, and Hegde,R.S. (1998) DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J. Mol. Biol., 276, 809-818.
19. Kim,S.S., Tam,J.K, Wang,A.F. and Hegde,R.S. (2000) The structural basis of DNA target discrimination, by papillomavirus E2 proteins. J. Biol. Chem., 275, 31245-31254.
20. Alexander,K.A. and Phelps,W.C. (1996) A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: A hierarchy of E2-bindipg sites. Biochemistry, 35, 9864-9872.
21. Falconi,M., Santolamazza,A., Eliseo,T., de Prat Gay,G., Cicero,D.O. and Desideri,A. (2007) Molecular dynamics of the DNA-binding domain of the papillomavirus E2 transcriptional regulator uncover differential properties for DNA target accommodation. FEBS J., 274, 2385-2395.
22. Cicero,D.O., Nadra,A.D., Eliseo,T., Dellarole,M., Paci,M. and de Prat Gay,G. (2006) Structural and thermodynamic basis for the enhanced transcriptional control by the human papillomavirus strain-16 E2 protein. Biochemistry, 45, 6551-6560.
23. Ferreiro,D.U., Dellarole,M., Nadra,A.D. and de Prat Gay,G. (2005) Free energy contributions to direct readout of a DNA sequence. J. Biol. Chem., 280, 32480-32484.
24. Nadra,A.D., Eliseo,T., Mok,Y.K., Almeida,C.L., Bycroft,M., Paci,M., de Prat Gay,G. and Cicero,D.O. (2004) Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold. J. Biomol. NMR, 30, 211-214.
25. Ferreiro,D.U. and de Prat Gay,G. (2003) A protein-DNA binding mechanism proceeds through multi-state or two-state parallel pathways. J. Mol. Biol., 331, 89-99.
26. Ferreiro,D.U., Lima,L.M., Nadra,A.D., Alonso,L.G., Goldbaum,F.A. and de Prat Gay,G. (2000) Distinctive cognate sequence discrimination, bound DNA conformation, and binding modes in the E2 C-terminal domains from prototype human and bovine papillomaviruses. Biochemistry, 39 14692-14701.
27. Newhouse,C.D. and Silverstein,S.J. (2001) Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication. J. Virol., 75, 1722-1735.
28. Hooley,E., Fairweather,V., Clarke,A.R., Gaston,K. and Brady,R.L. (2006) The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein. Nucleic Acids Res., 34, 3897-3908.
29. Muller,F., Giroglou,T. and Sapp,M. (1997) Characterization of the DNA-binding activity of the E1 and E2 proteins and the E1/E2 complex of human papillomavirus type 33. J. Gen. Virol., 78(Pt 4), 911-915.
30. Rozenberg,H., Rabinovich,D., Frolow,F., Hegde,R.S. and Shakked,Z. (1998) Structural code for DNA recognition revealed in crystal structures of papillomavirus E2-DNA targets [see comments]. Proc. Natl Acad. Sci. USA, 95, 15194-15199.
31. Hizver,J., Rozenberg,H., Frolow,F., Rabinovich,D. and Shakked,Z. (2001) DNA bending by an adenine - thymine tract and its role in gene regulation. Proc. Natl Acad. Sci. USA, 98, 8490-8495.
32. Hegde,R.S. and Androphy,E.J. (1998) Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: Implications for its DNA binding-site selection mechanism. J. Mol. Biol., 284 1479-1489.
33. Bedrosian,C.L. and Bastia,D. (1990) The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: Protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity. Virology, 174, 557-575.
34. Zimmerman,J.M. and Maher,L.J. III (2003) Solution measurement of DNA curvature in papillomavirus E2 binding sites. Nucleic Acids Res., 31, 5134-5139.
35. Byun,K.S. and Beveridge,D.L. (2004) Molecular dynamics simulations of papilloma virus E2 DNA sequences: Dynamical models for oligonucleotide structures in solution. Biopolymers, 73, 369-379.
36. Rohs,R., Sklenar,H. and Shakked,Z. (2005) Structural and energetic origins of sequence-specific DNA bending: Monte Carlo simulations of papillomavirus E2-DNA binding sites. Structure, 13, 1499-1509.
37. Remm,M., Brain,R. and Jenkins,J.R. (1992) The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res., 20, 6015-6021.
38. Chiang,C.M., Dong,G., Broker,T.R. and Chow,L.T. (1992) Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins. J. Virol., 66, 5224-5231.
39. Sverdrup,F. and Khan,S.A. (1995) Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. J. Virol., 69, 1319-1323.
40. Lu,J.Z., Sun,Y.N., Rose,R.C., Bonnez,W. and McCance,D.J. (1993) Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin. J. Virol., 67, 7131-7139.
41. Stubenrauch,F., Lim,H.B. and Laimins,L.A. (1998) Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol., 72, 1071-1077.
42. Demeret,C., Le Moal,M., Yaniv,M. and Thierry,F. (1995) Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic Acids Res., 23, 4777-4784.
43. Dong,G., Broker,T.R. and Chow,L.T. (1994) Human papilloma-virus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol. 68, 1115-1127.
44. Steger,G. and Corbach,S. (1997) Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol., 71, 50-58.
45. Rapp,B., Pawellek,A., Kraetzer,F., Schaefer,M., May,C., Purdie,K., Grassmann,K. and Iftner,T. (1997) Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J. Virol., 71, 6956-6966.
46. Thierry,F. and Howley,P.M. (1991) Functional analysis of E2-mediated repression of the BPV18 P105 promoter. New Biol., 3, 90-100.
47. Demeret,C., Desaintes,C., Yaniv,M. and Thierry,F. (1997) Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol., 71, 9343-9349.
48. Soeda,E., Ferran,M.C., Baker,C.C. and McBride,A.A. (2006) Repression of HPV16 early region transcription by the E2 protein. Virology.
49. Kim,K., Garner-Hamrick,P.A., Fisher,C., Lee,D. and Lambert,P.F. (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol., 77 12450-12459.
50. Rosl,F., Arab,A., Klevenz,B. and zur Hausen,H. (1993) The effect of DNA methylation on gene regulation of human papilloma-viruses. J. Gen. Virol., 74(Pt 5), 791-801.
51. Bhattacharjee,B. and Sengupta,S. (2006) CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology, 354, 280-285.
52. Wiley,D.J., Huh,J., Rao,J.Y.; Chang,C., Goetz,M., Poulter,M., Masongsong,E, Chang,C.I. and Bernard,H.U. (2005) Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J. Acquir. Immune Defic. Syndr. (1999), 39, 143-451.
53. Badal,S., Badal,V., Calleja-Macias,I.E., Kanlantari,M., Chuang,L.S., Li,B.F. and Bernard,H.U. (2004) The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology, 324 483-492.
54. Kalantari,M., Calleja-Mácias,I.E., Tewari,D., Hagmar,B., Lie,K., Barrera-Saldana,H.A., Wiley,D.J. and Bernard,H.U. (2004) Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol., 78, 12762-12772.
55. Badal,V., Chuang,L.S., Tan,E.H., Badal,S., Villa,L.L., Wheeler,C.M., Li,B.F. and Bernard,H.U. (2003) CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol., 77, 6227-6234.
56. Ozbun,M.A. and Meyers,C. (1998) Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology, 248, 218-230.
57. Doorbar,J. (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci., 110, 525-541.
58. Tan,S., Leong,L.E., Walker,P.A. and Bernard,H. (1994) The human papillomavirus type 16 E2 transacription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol., 68, 6411-6420.
59. Klucevsek,K., Wertz,M., Lucchi,J., Leszczynski,A. and Moroianu,J. (2007) Characterization of the nuclear localization signal of high risk HPV16 E2 protein. Virology, 360, 191-198.
60. Hou,S.X., Wu,S.Y. and Chiang,C.M. (2002) Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding. J. Biol. Chem., 277, 45619-45629
61. Parish,J.L., Kowalczyk,A., Chen,H.T., Roeder,G.E., Sessions,R., Buckle,M. and Gaston,K. (2006) E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J. Virol., 80, 4580-4590.
62. Garcia-Vallve,S., Iglesias-Rozas,J.R., Alonso,A. and Bravo,I.G. (2006) Different papillomaviruses have different repertoires of transcription factor binding sites: Convergence and divergence in the upstream regulatory region. BMC Evol. Biol., 6, 20.
63. Schneider,T.D. and Stephens,R.M. (1990) Sequence logos: A new way to display consensus sequences. Nucleic Acids Res., 18, 6097-6100.
64. Büchen-Osmond,C. (2003) The Universal Virus Database ICTVdB. Computing in Science & Engineering, 5, 16-25.
65. Tatusova,T.A. and Madden,T.L. (1999) BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol. Lett., 174, 247-250.
66. Chenna,R., Sugawara,H., Koike,T., Lopez,R., Gibson,T.J., Higgins,D.G. and Thompson,J.D. (2003) Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res., 31, 3497-3500.
67. Clamp,M., Cuff,J., Searle,S.M. and Barton,G.J. (2004) The Jalview Java alignment editor. Bioinformatics, 20, 426-427.
68. Crooks,G.E., Hon,G., Chandonia,J.M. and Brenner,S.E. (2004) WebLogo: A sequence logo generator. Genome Res., 14, 1188-1190.
69. Vacic,V., Iakoucheva,L.M. and Radivojac,P. (2006) Two Sample Logo: A graphical representation of the differences between two sets of sequence alignments. Bioinformatics, 22, 1536-1537.
70. Berg,O.G. and von Hippel,P.H. (1988) Selection of DNA binding sites by regulatory proteins. II. The binding specificity of cyclic AMP receptor protein to recognition sites. J. Mol. Biol., 200, 709-723.
71. Berg,O.G. and von Hippel,P.H. (1987) Selection of DNA binding sites by regulatory proteins. Statistical-mechanical theory and application to operators and promoters. J. Mol. Biol., 193, 723-750.
72. Berg,O.G. and von Hippel,P.H. (1988) Selection of DNA binding sites by regulatory proteins. Trends Biochem. Sci., 13, 207-211.
73. Workman,C.T., Yin,Y., Corcoran,D.L., Ideker,T., Stormo,G.D. and Benos,P.V. (2005) enoLOGOS: A versatile web tool for energy normalized sequence logos. Nucleic Acids Res., 33, W389-W392.
74. MacQueen,J.B. (1967) In Proceedings of 5-th Berkeley Symposium on Mathematical Statistics and Probability. University of California Press, Berkeley, Vol. 1, pp. 281-297.
75. Rivals,I., Personnaz,L., Taing,L. and Potier,M.C. (2007) Enrichment or depletion of a GO category within a class of genes: Which test? Bioinformatics, 23, 401-407.
76. Liang,H., Petros,A.M., Meadows,R.P., Yoon,H.S., Egan,D.A., Walter,K., Holzman,T.F., Robins,T. and Fesik,S.W. (1996) Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: Evidence for flexible DNA-binding regions. Biochemistry, 35, 2095-2103.
77. Pyles,E.A. and Lee,J.C. (1998) Escherichia coli cAMP receptor protein-DNA complexes. 2. Structural asymmetry of DNA bending. Biochemistry, 37, 5201-5210.
78. Ramirez-Carrozzi,V. and Kerppola,T. (2003) Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1. Mol. Cell. Biol., 23 1737-1749.
79. King,D.A., Zhang,L., Guarente,L. and Marmorstein,R. (1999) Structure of a HAP1-DNA complex reveals dramatically asymmetric DNA binding by a homodimeric protein. Nat. Struct. Biol., 6, 64-71.
80. Riumann,B.E., Rould,M.A., Pabo,C.O. and Sauer,R.T. (1994) DNA recognition by beta-sheets in the Arc repressor-operator crystal structure. Nature, 367, 754-757.
81. Winston,R.L., Ehley,J.A., Baird,E.E., Dervan,P.B. and Gottesfeld,J.M. (2000) Asymmetric DNA binding by a homodimeric bHLH protein. Biochemistry, 39, 9092-9098.
82. Kalodimos,C.G., Bonvin,A.M., Salinas,R.K., Wechselberger,R., Boelens,R. and Kaptein,R. (2002) Plasticity in protein-DNA recognition: Lac repressor interacts with its natural operator 01 through alternative conformations of its DNA-binding domain. EMBO J., 21, 2866-2876.
83. Sarai,A. and Takeda,Y. (1989) Lambda repressor recognizes the approximately 2-fold symmetric half-operator sequences asymmetrically. Proc. Natl Acad. Sci USA, 86, 6513-6517.
84. Ensser,A. and Pfister,H. (1990) Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res., 18, 3919-3922.
85. Li,R., Knight,J., Bream,G., Stenlund,A. and Botchan,M. (1989) Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev., 3, 510-526.
86. Ptashne,M. (2004) A Genetic Switch - Phage Lambda Revisited, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
87. Brown,J.H. (2006) Breaking symmetry in protein dimers: Designs and functions. Protein Sci., 15, 1-13.
88. Gloss,B., Bernard,H.U., Seedorf,K. and Klock,G. (1987) The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J., 6, 3735-3743.
89. Fontaine,V., van der Meijden,E., de Graaf,J., ter Schegget,J. and Struyk,L. (2000) A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. Virology, 272, 40-49.
90. Thomassin,H., Flavin,M., Espinas,M.L. and Grange,T. (2001) Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J., 20, 1974-1983.
91. Matsuo,K., Silke,J., Georgiev,O., Marti,P., Giovannini,N. and Rungger,D. (1998) An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA. EMBO J., 17, 1446-1453.
92. Kirillov,A., Kistler,B., Mostoslavsky,R., Cedar,H., Wirth,T. and Bergman,Y. (1996) A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat. Genet., 13, 435-441.
93. Wu,M.H., Chan,J.Y., Liu,P.Y., Liu,S.T. and Huang,S.M. (2007) Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells. Int. J. Biochem. Cell Biol., 39, 413-425.
94. Bernard,H.U. (2006) In Saveria Campo,M. (ed.), Papillomavirus Research: From Natural History to Vaccines and Beyond. Caisreir Academic Press, Wymondham, Vol. Chapter 2, pp. 11-18.
95. Stubenrauch,F., Leigh,I.M. and Pfister,H. (1996) E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J. Virol., 70, 119-126.
96. Guido,M.C., Zamorano,R., Garrido-Guerrero,E., Gariglio,P. and Garcia-Carranca,A. (1992) Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. J. Gen. Virol., 73(Pt 6), 1395-1400.
97. Sichero,L. and Villa,L.L. (2006) Epidemiological and functional implications of molecular variants of human papillomavirus. Braz. J. Med. Biol. Res., 39, 707-717.